H
C. Theunissen et al.
PRACTICAL SYNTHETIC PROCEDURES
HRMS (ESI): m/z calcd for C21H24N [M + H]+: 290.1909; found:
290.1902.
IR (ATR): 2955, 2927, 2870, 2361, 2341, 2189, 1576, 1456, 1411,
1383, 1264, 1105, 1069, 1023, 1000, 887, 816, 782, 752, 724, 492
cm–1.
N-[1-(2-Chlorophenyl)pentylidene]pent-1-yn-1-amine (6b)
Obtained as a mixture of Z- and E-isomers in a 50:50 ratio. Prepared
according to procedure 3 from pent-1-yn-1-ylcopper (2a; 131 mg,
1.00 mmol), 1-(2-chlorophenyl)pentan-1-imine (783 mg, 4.00
mmol), and 1,2-dimethylimidazole (175 μL, 1.97 mmol) in MeCN
(4 mL). Purified by flash column chromatography [on triethyl-
amine-deactivated silica gel, PE–Et2O (95:5). Note: the column had
to be run quickly as the compound is rather sensitive to silica gel];
yield: 180 mg (0.69 mmol, 69%); pale yellow oil.
1H NMR (400 MHz, CDCl3): δ (major) = 7.24–7.12 (m, 2 H), 6.99
(d, J = 7.1 Hz, 1 H), 4.16 (s, 2 H), 4.14 (s, 2 H), 4.02 (s, 5 H), 2.74
(t, J = 7.6 Hz, 2 H), 2.41 (s, 3 H), 2.27 (s, 3 H), 1.70 (app quint, J =
7.5 Hz, 2 H), 1.46 (app sext, J = 7.4 Hz, 2 H), 0.98 (t, J = 7.3 Hz, 3
H); δ (minor) = 7.24–7.12 (m, 3 H), 4.49 (s, 2 H), 4.30 (s, 2 H), 4.27
(s, 5 H), 3.03 (t, J = 7.7 Hz, 2 H), 2.35 (s, 6 H), 1.63 (app quint, J =
7.5 Hz, 2 H), 1.46 (app sext, J = 7.4 Hz, 2 H), 1.00 (t, J = 7.2 Hz, 3
H).
13C NMR (100 MHz, CDCl3): δ (major) = 185.8, 140.5, 137.2,
132.7, 130.2, 125.6, 123.1, 87.6, 87.1, 71.1, 69.8, 68.6, 66.6, 41.0,
28.1, 22.6, 20.4, 16.7, 14.0; δ (minor) = 185.7, 139.9, 137.9, 134.3,
130.7, 125.4, 125.3, 93.2, 86.4, 71.4, 69.9, 69.0, 66.8, 38.4, 28.4,
23.0, 20.6, 17.0, 13.9.
IR (ATR): 2958, 2929, 2866, 2207, 1590, 1467, 1429, 1340, 1182,
1033, 745.
1H NMR (300 MHz, CDCl3): δ = 7.43–7.39 and 7.17–7.13 (m, 1 H,
stereoisomers), 7.36–7.27 (m, 3 H), 3.06 and 2.72 (t, J = 7.5 Hz, t,
J = 7.4 Hz, 2 H, stereoisomers), 2.57 and 2.24 (t, J = 6.9 Hz, t, J =
6.8 Hz 2 H, stereoisomers), 1.68–1.61 (m, 2 H), 1.52–1.28 (m, 4 H),
1.06 and 0.73 (t, J = 7.3 Hz, t, J = 7.3 Hz, 3 H, stereoisomers), 0.92
and 0.89 (t, J = 7.3 Hz, t, J = 7.2 Hz, 3 H, stereoisomers).
13C NMR (75 MHz, CDCl3): δ = 184.3 and 181.8 (stereoisomers),
138.8 and 138.7 (stereoisomers), 131.7, 130.3, 130.0, 129.8, 129.7,
129.6 and 127.7 (stereoisomers), 126.7 and 126.6 (stereoisomers),
96.3 and 90.1 (stereoisomers), 82.1 and 81.4 (stereoisomers), 39.8
and 36.4 (stereoisomers), 28.1 and 27.9 (stereoisomers), 22.7, 22.6,
22.4, 22.3, 22.1 and 21.5 (stereoisomers) 13.9, 13.7, 13.6 and 13.1
(stereoisomers).
HRMS (ESI): m/z calcd for C25H27FeN [M]+: 397.1493; found:
397.1509.
Diisopropyl (Pent-1-yn-1-yl)phosphonate (8a)
Prepared according to procedure 4 from pent-1-yn-1-ylcopper (2a;
9.8 g, 75.0 mmol), diisopropyl phosphite (50.3 mL, 300.0 mmol),
and N-methylimidazole (12.0 mL, 150.5 mmol) in DMF (150 mL).
Purified by flash column chromatography (pentane–EtOAc, 50:50);
yield: 16.0 g (68.9 mmol, 92%); colorless oil.
IR (ATR): 2982, 2205, 1385, 1255, 981 cm–1.
1H NMR (300 MHz, CDCl3): δ = 4.67–4.60 (m, 2 H), 2.24 (td, J =
6.9 Hz and JH,P = 4.2 Hz, 2 H), 1.53 (tq, J = 7.5, 7.2 Hz, 2 H), 1.28
(d, J = 7.2 Hz, 12 H), 0.93 (t, J = 6.6 Hz, 3 H).
HRMS (ESI): m/z calcd for C16H21ClN [M + H]+: 262.1363; found:
262.1365.
N-[1-(2,3-Dimethylphenyl)pentylidene]pentyn-1-yn-1-amine
(6c)
13C NMR (75 MHz, CDCl3): δ = 102.1 (d, JC,P = 52.5 Hz), 72.2 (d,
J
C,P = 300.0 Hz), 72.0 (d, JC,P = 5.3 Hz), 24.4 (d, JC,P = 4.5 Hz), 23.7
Obtained as a mixture of Z- and E-isomers in a 40:60 ratio. Prepared
according to procedure 3 from pent-1-yn-1-ylcopper (2a; 1.0 g, 7.6
mmol), 1-(2,3-dimethylphenyl)pentan-1-imine (5.8 g, 30.6 mmol),
and 1,2-dimethylimidazole (1.35 mL, 15.2 mmol) in MeCN (30
mL). Purified by flash column chromatography [on triethylamine-
deactivated silica gel, PE–Et2O (95:5). Note: the column had to be
run quickly as the compound is rather sensitive to silica gel]; yield:
1.45 g (5.7 mmol, 75%); pale yellow oil.
(d, JC,P = 4.8 Hz), 21.3, 21.2, 13.3.
31P NMR (121 MHz, CDCl3): δ = –8.7.
HRMS (ESI): m/z calcd for C11H22O3P [M + H]+: 233.1307; found:
233.1305.
Dibutyl (Pent-1-yn-1-yl)phosphonate (8b)
Prepared according to procedure 4 from pent-1-yn-1-ylcopper (2a;
2.6 g, 20.0 mmol), dibutyl phosphite (15.7 mL, 80.0 mmol), and N-
methylimidazole (3.2 mL, 4.0 mmol) in DMF (40 mL). Purified by
flash column chromatography (cyclohexane–EtOAc, 60:40); yield:
4.8 g (18.4 mmol, 92%); pale yellow oil.
IR (ATR): 2958, 2929, 2871, 2361, 2341, 1597, 1456, 1378, 1337,
1274, 1177, 1087, 1017, 989, 784, 749, 722 cm–1.
1H NMR (300 MHz, CDCl3): δ (major) = 7.17–7.06 (m, 2 H), 6.90–
6.86 (m, 1 H), 2.65 (t, J = 7.5 Hz, 2 H), 2.29 (s, 3 H), 2.22 (t, J = 6.8
Hz, 2 H), 2.13 (s, 3 H), 1.66–1.58 (m, 2 H), 1.56–1.26 (m, 4 H), 0.91
(t, J = 7.3 Hz, 3 H), 0.69 (t, J = 7.3 Hz, 3 H); δ (minor ) = 7.17–7.06
(m, 3 H), 2.92 (t, J = 7.6 Hz, 2 H), 2.55 (t, J = 6.9 Hz, 2 H), 2.13 (s,
3 H), 2.25 (s, 3 H), 1.66–1.58 (m, 2 H), 1.56–1.26 (m, 4 H), 1.05 (t,
J = 7.3 Hz, 3 H), 0.89 (t, J = 7.0 Hz, 3 H).
13C NMR (75 MHz, CDCl3): δ (major) = 186.2, 140.2, 137.3, 132.7,
130.0, 125.5, 123.2, 88.8, 82.7, 41.1, 28.1, 22.7, 22.6, 21.7, 20.4,
16.6, 14.0, 13.1; δ (minor) = 187.1, 140.0, 137.8, 134.2, 130.5,
125.4, 125.3, 94.1, 81.8, 38.1, 28.3, 23.0, 22.9, 22.2, 20.6, 16.9,
13.9, 13.7.
IR (ATR): 2961, 2204, 1272, 1063, 1022, 992, 794 cm–1.
1H NMR (300 MHz, CDCl3): δ = 4.05 (app q, J = 7.6 Hz, 4 H), 2.30
(td, J = 7.0 Hz and JH,P = 4.3 Hz, 2 H), 1.73–1.52 (m, 6 H), 1.41 (app
sext, J = 7.6 Hz, 4 H), 1.00 (t, J = 7.3 Hz, 3 H), 0.92 (t, J = 7.6 Hz,
6 H).
13C NMR (75 MHz, CDCl3): δ = 103.0 (d, JC,P = 52.4 Hz), 70.7 (d,
JC,P = 300.6 Hz), 66.7 (d, JC,P = 5.6 Hz), 32.3 (d, JC,P = 7.3 Hz), 21.2
(d, JC,P = 4.4 Hz), 21.1 (d, JC,P = 2.3 Hz), 18.8, 13.7, 13.5.
31P NMR (161 MHz, CDCl3): δ = –5.1.
HRMS (ESI): m/z calcd for C13H26O3P [M + H]+: 261.1620; found:
HRMS (ESI): m/z calcd for C18H26N [M + H]+: 256.2065; found:
256.2065.
261.1617.
Diethyl (4-Phenylbut-1-yn-1-yl)phosphonate (8c)
N-[1-(2,3-Dimethylphenyl)pentylidene](ferrocenylethynyl)-1-
amine (6d)
Prepared according to procedure 4 from 4-phenylbut-1-yn-1-ylcop-
per (2c; 385 mg, 2.0 mmol), diethyl phosphite (1.0 mL, 8.0 mmol),
and N-methylimidazole (320 μL, 4.0 mmol) in DMF (4 mL). Puri-
fied by flash column chromatography (cyclohexane–EtOAc,
50:50); yield: 513 mg (1.93 mmol, 96%); pale yellow oil.
Obtained as a mixture of Z- and E-isomers in a 38:62 ratio. Prepared
according to procedure 3 from ferrocenylethynylcopper (2l; 273 g,
1.00 mmol), 1-(2,3-dimethylphenyl)pentan-1-imine (757 m g, 4.00
mmol), and 1,2-dimethylimidazole (175 μL, 1.97 mmol) in MeCN
(4 mL). Purified by flash column chromatography [on triethyl-
amine-deactivated silica gel, PE–EtOAc (90:10). Note: the column
had to be run quickly as the compound is rather sensitive to silica
gel]; yield: 246 mg (0.62 mmol, 62%); pale orange oil.
IR (ATR): 2984, 2204, 1262, 1022, 974, 752 cm–1.
1H NMR (300 MHz, CDCl3): δ = 7.29–7.22 (m, 2 H), 7.21–7.13 (m,
3 H), 4.08–3.95 (m, 4 H), 2.84 (t, J = 7.3 Hz, 2 H), 2.60 (td, J = 7.3
Hz and JH,P = 4.3 Hz, 2 H), 1.27 (t, J = 7.1 Hz, 6 H).
Synthesis 2014, 46, A–J
© Georg Thieme Verlag Stuttgart · New York